🇺🇸 FDA
Pipeline program

Anti-thymocyte globulin

199/14004

Phase 3 small_molecule completed

Quick answer

Anti-thymocyte globulin for Aplastic Anemia is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Aplastic Anemia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials